对于儿科格拉登尼戈综合征的Ceftazidime-Cefazolin实证疗法
Brendan K Tao1, Fahad Alotaibi2, Alastair McAlpine2
1Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
The Annals of otology, rhinology, and laryngology
|November 20, 2024
概括
在儿童中,渐症综合征 (GS) 是耳部感染的并发症,可能是严重的. 这份病例报告强调了使用宽谱抗生素成功治疗的成功方法,该抗生素涵盖了诸如Pseudomonas aeruginosa等常见病原体.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 儿童传染病 儿童传染病
- 神经学 神经学
背景情况:
- 格拉登尼戈综合征 (GS) 是石油炎的罕见并发症,通常源于急性中耳炎.
- 它经典地呈现出耳鼻,绑架神经麻和面部疼痛.
- Pseudomonas aeruginosa 是一个常见的病原体,但文献经常报告在GS管理中对其缺乏足够的抗生素覆盖.
研究的目的:
- 描述一个儿科格拉登尼戈综合征病例.
- 强调广泛的抗生素覆盖的重要性,包括Pseudomonas aeruginosa,在治疗GS.
主要方法:
- 这项研究是个案例报告.
- 一个5岁的男孩有症状暗示GS和成像证据的石性炎经验性治疗.
主要成果:
- 这位患者出现了中耳炎,食otropia,和石油的apicitis.
- 尽管存在未确定的致病生物,但经验性静脉注射Ceftazidime和Cefazolin导致没有手术的完全康复.
- 治疗方案为常见病原体提供了足够的覆盖,包括Pseudomonas aeruginosa.
结论:
- 经验广泛的抗生素治疗对于疑似骨底部感染至关重要,如格拉登尼戈综合征,尤其是不确定的培养结果.
- 抗生素治疗方案应确保覆盖链球菌,葡萄球菌和 Pseudomonas aeruginosa.
- 这种方法可以预防进一步的内并发症,并改善患者的治疗结果.
相关概念视频
01:28Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
109
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
109
01:28Pleural Effusion II: Symptoms and Management
154
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
154
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:24Cystic Fibrosis: Management
142
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
142